27-28 September, 2018

Boston, USA

 

Key Topics to Be Addressed:

  • Explore & understand different types of pain and mechanism of actions to advance novel & patient-centric approaches to pain drug development
  • Assess current pain therapeutics as a catalyst for better pain R&D with case studies from Caventure Drug Discovery, Inc., Rottapharm Biotech & University of Michigan
  • Discover novel analgesic targets from latest pre-clinical approaches to novel pain drugs development with solution led talks delivered by leading biotechs and academics such as Carica Health, Anavex Life Sciences & Saint Louis University
  • Through case studies and deep discussions with key experts from NIH, McGill University & Northeastern University benchmark and overcome key translational challenges such as lack of predictability of models, biomarker identification and clinical design of novel pain drug development
  • Find out about the most innovative approaches of pain drugs currently in clinical development from leaders such as Mesoblast, Chromocell, AcheBlios Therapeutics & Indiana University

 

 

Industry Pricing

Standard Pricing
Conference Only $1,999.00
Conference + 1 Workshop $2,498.00
Workshop Only $499.00

Academic Pricing

Standard Pricing
Conference Only $1,499.00
Conference + 1 Workshop $1,898.00
Workshop Only $399.00